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Abstract 
Background: The industrial production of riboflavin mostly relies on the microbial fermentation of flavinogenic 
microorganisms and Ashbya gossypii is the main industrial producer of the vitamin. Accordingly, bioengineering strat‑
egies aimed at increasing riboflavin production in A. gossypii are highly valuable for industry.
Results: We analyze the contribution of all the RIB genes to the production of riboflavin in A. gossypii. Two important 
metabolic rate‑limiting steps that limit the overproduction of riboflavin have been found: first, low mRNA levels of 
the RIB genes hindered the overproduction of riboflavin; second, the competition of the AMP branch for purinogenic 
precursors also represents a limitation for riboflavin overproduction. Thus, overexpression of the RIB genes resulted in 
a significant increase in riboflavin yield. Moreover, both the inactivation and the underexpression of the ADE12 gene, 
which controls the first step of the AMP branch, also proved to have a positive effect on riboflavin production. Accord‑
ingly, a strain that combines both the overexpression of the RIB genes and the underexpression of the ADE12 gene 
was engineered. This strain produced 523 mg/L of riboflavin (5.4‑fold higher than the wild‑type), which is the highest 
titer of riboflavin obtained by metabolic engineering in A. gossypii so far.
Conclusions: Riboflavin production in A. gossypii is limited by a low transcription activity of the RIB genes. Flux limita‑
tion towards AMP provides committed substrate GTP for riboflavin overproduction without detrimental effects on 
biomass formation. A multiple‑engineered Ashbya strain that produces up to 523 mg/L of riboflavin was generated.
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Background
Riboflavin (vitamin B2) is an essential nutrient for 
humans and animals that must be obtained from the diet. 
Accordingly, it is usually included in fortified foods and 
multivitamin supplements [1]. The production of ribofla-
vin by microbial fermentation is a paradigmatic example 
of white biotechnology using different cell factories such 
as Bacillus subtilis, Candida flareri and, especially, Ash-
bya gossypii [2]. Indeed, nearly half the world production 
of riboflavin (8000 tons per year) is obtained through the 
fermentation of A. gossypii strains [3].
Ashbya gossypii is a filamentous hemiascomycete 
that overproduces riboflavin naturally. Thus, industrial 
strains of A. gossypii for riboflavin production have 
been obtained by a combination of random chemical 
mutagenesis with metabolic engineering of the purine 
pathway [1]. The development of rational approaches for 
the manipulation of A. gossypii is now supported with 
novel genomic tools, including a genome-scale metabolic 
model of A. gossypii (iRL766) [4]. In addition, new strains 
of A. gossypii for the production of folic acid and single-
cell oil have been described recently [5, 6].
The biosynthesis of riboflavin is initiated from two 
main precursors: GTP and ribulose-5-phosphate 
(Ribu5P) (Fig.  1). GTP is synthesized from the purine 
pathway and its availability has been shown to be impor-
tant for riboflavin production. In this regard, the increase 
in metabolic flux towards the synthesis of GTP results in 
the overproduction of riboflavin [7–9]. GTP and Ribu5P 
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are transformed into riboflavin via a 7-reaction pathway 
that is controlled by the RIB genes [10] (Fig. 1). There are 
two branches that converge to form 6,7-Dimethyl-8-ribi-
tyl-lumazine (DRL). One branch synthesizes 5-Amino-
6-ribitylamino-2,4-(1H,3H)-pyrimidinedione (ArP) from 
GTP through four consecutive reactions catalyzed by the 
enzymes RIB1, RIB7, RIB2 and an unknown phosphatase 
(Fig.  1). On the other branch, RIB3 transforms Ribu5P 
into 3,4-Dihydroxy-2-butanone-4-phosphate (DHBP). 
Then, both ArP and DHBP are conjugated by RIB4 to 
produce DRL, which is subsequently converted into ribo-
flavin by the product of the RIB5 gene (Fig. 1). All the RIB 
genes have been identified in A. gossypii [11] but so far 
their contribution to riboflavin overproduction has not 
been fully characterized.
In A. gossypii riboflavin is mainly produced during the 
production phase, when the growth rate decreases. In 
contrast, exponential growth occurs during the trophic 
phase, when riboflavin yield is minimal [10]. Accord-
ingly, riboflavin biosynthesis is tightly regulated at both 
the enzymatic and transcriptional levels as previously 
described both for the purine and RIB pathways in A. 
gossypii [7, 9, 11]. In this regard, transcriptional regula-
tion occurred during the riboflavin production phase has 
been predicted by a genome-scale metabolic reconstruc-
tion, thus revealing a number of target genes that can be 
considered as good candidates for metabolic engineer-
ing approaches to increase the production of riboflavin. 
Interestingly, the RIB2, RIB3, RIB4 and RIB5 genes were 
predicted to be up-regulated genes during riboflavin 
overproduction in A. gossypii [4]. In good agreement, sev-
eral reports have also shown a relationship between the 
transcriptional regulation of RIB genes and an increase of 
the riboflavin biosynthesis in several organisms [12–14].
As mentioned above, riboflavin overproduction has 
been achieved through the deregulation of the purine 
pathway at different levels to increase the pool of GTP 
[7–9]. It is noteworthy that both the GMP and AMP 
branches of the purine pathway compete for the common 
precursor IMP. Thus, in C. famata (C. flareri), the heter-
ologous expression of both the transcription factor SEF1 
and the purinogenic enzyme IMP dehydrogenase from 
Debaryomyces hansenii, together with the overexpression 
of the RIB1 and RIB7 genes, resulted in a 4.1-fold increase 
in riboflavin production [15]. Hence, a limiting riboflavin 
biosynthetic pathway may mask the identification of new 
mutations improving the production of riboflavin.
The objective of this work was to study the relative con-
tribution of each RIB gene to the riboflavin production 
process in A. gossypii. Accordingly, the transcriptional 
pattern of the RIB genes was analyzed and the potential 
impact of each RIB gene on the metabolic control of ribo-
flavin production was determined by overexpression of 
single RIB genes as well as by combining the overexpres-
sion of up to five RIB genes to deregulate the entire path-
way. In addition, the performance of a deregulated strain 
overexpressing the full set of RIB genes was challenged 
to support higher riboflavin productivity in response to a 
major availability of GTP substrate. This was achieved by 
metabolic flux re-direction towards GMP by reducing the 
synthesis of AMP from IMP. In summary, we found that 
both the availability of GTP substrate from the purine 
pathway and the transcriptional activity of the RIB genes 
are rate-limiting steps for riboflavin overproduction.
Results
Transcriptional analysis of the RIB genes in A. gossypii
As previously described, several reports have established 
a relationship between the transcriptional regulation of 
some of the RIB genes and the increase of riboflavin pro-
duction [11–14]. In addition, the analysis of metabolic 
flux changes related to the production of riboflavin using 
the iRL766 model predicted the up-regulation of most 
of the RIB genes during the production phase in A. gos-
sypii [4]. Accordingly, we were prompted to determine 
the RNA levels of all the six RIB genes encoded in the 
genome of A. gossypii.
The transcriptional analysis of the RIB genes was car-

























Fig. 1 Diagram of the riboflavin biosynthetic pathway. The 
genes manipulated in this work are indicated in bold. Dashed 
lines indicate multistep reactions. Ribu5P ribulose‑5‑phosphate; 
ribo5P ribose‑5‑phosphate; DARPP 2,5‑diamino‑6‑ribosylamino‑
4(3H)‑pyrimidinedione phosphate; DArPP 2,5‑diamino‑6‑
ribitylamino‑4‑(3H)‑pyrimidinedione‑5′‑phosphate; ArPP 
5‑amino‑6‑ribitylamino‑2,4‑(1H,3H)‑pyrimidinedione‑5′‑phosphate; 
ArP 5‑amino‑6‑ribitylamino‑2,4‑(1H,3H)‑pyrimidinedione; DHBP 
3,4‑dihydroxy‑2‑butanone‑4‑phosphate; DRL 6,7‑dimethyl‑8‑ribityl‑
lumazine
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cultures in both the trophic phase (24 h of culture) and 
the production phase (120  h of culture) were obtained. 
Quantitative analysis of the RIB genes in cDNA sam-
ples was carried out using the housekeeping gene ACT1 
as a reference [6]. With the exception of RIB4, the level 
of RNA for all the RIB genes was very low in both the 
trophic and production phases; ranging from 1–5   (for 
RIB2, RIB5 and RIB7) to 10–15 % (for RIB1 and RIB3) of 
the transcript level of the moderately transcribed gene 
ACT1 (Fig. 2). RIB4 showed a high transcriptional level, 
similar to that of the GPD gene (Fig. 2), whose promoter 
is widely used for gene overexpression in A. gossypii [9]. 
In contrast to the prediction of the iRL766 model, the 
transcription rate of the RIB genes showed no or only 
minor increments during the production phase (Fig. 2).
Single gene overexpression of the RIB genes in A. gossypii
The results reported above revealed that the transcrip-
tion of most of the RIB genes remains low throughout 
the trophic and production phases of A. gossypii culture. 
Accordingly we wished to determine the effect of the 
overexpression of each RIB gene on riboflavin production 
in A. gossypii. The RIB4 was excluded from the overex-
pressions experiments, since this gene already showed a 
high transcriptional level in the wild-type.
Gene overexpressions were carried out using an inte-
grative cassette harboring a geneticin-resistance selec-
tion marker and the strong promoter PAgGPD. The cassette 
was flanked by recombinogenic sequences for each RIB 
gene and was integrated by homologous recombination 
to replace the native promoter region of each gene. Over-
expression of the RIB genes was verified by qRT-PCR 
analysis (Additional file  1: Fig.  S1a) and the riboflavin 
production of the mutant strains was determined. As 
shown in the Fig. 3, the overexpression of RIB1, RIB2 or 
RIB3 triggered an increase in riboflavin production. The 
overexpression of either RIB1 or RIB3, which code for the 
first enzymes of each branch in the riboflavin pathway, 
induced the highest increases in riboflavin production. 
In contrast, the overexpression of either RIB5 or RIB7 
did not cause any significant change in the production of 
riboflavin (Fig. 3).
Global overexpression of the RIB genes in A. gossypii
We observed that overexpression of some of the RIB 
genes induced an increase in riboflavin production 
in A. gossypii. Thus, the low transcription rate of the 
RIB genes may be a limiting-rate step for riboflavin 
overproduction and, consequently, a maximal yield 
of riboflavin might be obtained with the overexpres-
sion of all the RIB genes. Accordingly, it was decided 
to overexpress all the RIB genes to quantify the ribofla-
vin production in a quintuple overexpressing strain. A 
loxP-KanMX-loxP selection marker was used for gene 
overexpression. The loxP repeated inverted sequences 
enabled the selection marker to be eliminated, and 
subsequently reused, by expressing a Cre recombinase 
after each round of transformation, as described else-
where [6]. The gene overexpression pipeline is depicted 
in Fig.  4a. The A329 strain, which overexpresses the 
RIB1, RIB2, RIB3, RIB5 and RIB7 genes, was obtained 
after 10 transformations either to integrate the PAgGPD 
into the target loci or to remove the KanMX selection 
marker (Fig.  4a). The overexpression of the RIB genes 























Fig. 2 Quantitative‑real time PCR of the RIB genes in A. gossypii. 
Relative transcription levels of the RIB genes in our wild‑type strain of 
A. gossypii during both the trophic phase (24 h, exponential growth) 
and the production phase (120 h, stationary growth). The GPD1 gene 
was included as a control. Transcription levels were normalized using 
the A. gossypii ACT1 gene as a reference. The results are the means 
of two independent experiments performed in duplicate and are 
expressed as a ratio of the cDNA abundances of the target genes 

























Fig. 3 Riboflavin production after the overexpression of RIB genes 
in A. gossypii. Quatification of riboflavin production in the A. gossypii 
strains that overexpress one of the RIB genes. The data are the means 
of three independent experiments performed in duplicate
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Riboflavin production was measured in the quintuple 
overexpressing strain and also in all the intermediate 
strains (Fig.  4b). As shown above, the overexpression 
of RIB3 alone triggered a remarkable increase in ribo-
flavin production (46  % more riboflavin than the WT 
strain). In addition, the combination of the overexpres-
sion of both RIB1 and RIB3 (strain A273) increased the 
riboflavin yield by more than 2.5-fold in comparison 
with the WT. Moreover, the overexpression of RIB5, 
RIB2 and RIB7 caused an additional increase in ribofla-
vin production with respect to the A273 strain. Overall, 
the A329 strain, which simultaneously overexpressed 
the RIB1, RIB2, RIB3, RIB5 and RIB7 genes, showed the 
highest level of riboflavin production (326.6 mg/L), rep-
resenting a 3.1-fold increase over the WT production 
(Fig. 4b).
Flux balance analysis of the purine pathway  
for riboflavin production
In the absence of enzymatic regulation constrains, the 
strain containing the overexpressed, deregulated ribo-
flavin biosynthetic pathway should not be limited in the 
riboflavin pathway itself, but rather it should be able to 
respond to increases in the pool of the GTP substrate by 
efficiently increasing the rate of riboflavin product forma-
tion. To assess this hypothesis we decided to increase the 
GTP supply available for riboflavin synthesis and deter-
mine the effect on riboflavin production in both the WT 
and RIB-overexpressing (A329) strains.
The purine pathway provides GTP, which is one of 
the main precursors of riboflavin. Since our previ-
ous results demonstrated that the deregulation of the 
purine pathway induces a significant increase of ribo-
flavin overproduction in A. gossypii [7–9], an increase 
in the intracellular pool of GTP could be correlated 
with a higher riboflavin yield in A. gossypii. IMP is the 
central metabolite of the purine pathway, which can 
subsequently be converted either to AMP or GMP via 
a two-branch pathway (Fig.  1). Thus, IMP metabolic 
flux towards GMP/GTP production compete with the 
AMP branch, which consists of two enzymatic reactions 
controlled by adenylosuccinate synthase (ADE12) and 
adenylosuccinate lyase (ADE13). Indeed, flux balance 
analysis of riboflavin production using the A. gossypii 
iRL766 model predicted that the AMP branch of the 
purine pathway is down-regulated during the produc-
tion phase, while the GMP branch, leading to GTP and 
thereafter riboflavin, is not transcriptionally regulated. 
These results suggest that a control over the IMP hub 
affects riboflavin production.
Accordingly, we used the A. gossypii iRL766 model to 
simulate a reduction in metabolic flux towards the AMP 
branch by decreasing the activity of the Ade12 enzyme 
(Fig. 1). The in silico simulation comprised 316 metabolic 
reactions, including enzymatic cofactors that could affect 
metabolic flux exchange in both the purine and ribofla-
vin pathways. The output of the model predicted a linear 
increase in riboflavin production that was directly cor-
related with the reduction in Ade12 activity (Additional 
file  2: Fig.  S2). Thus, in order to increase the supply of 
GTP available for riboflavin synthesis in A. gossypii, the 
ADE12 gene can be considered a solid candidate for met-
abolic engineering through deletion. In addition, engi-
neering the IMP metabolic hub can serve to analyze the 
performance of a deregulated, overexpressed riboflavin 
pathway in response to a greater availability of guanine 
precursors.
Metabolic engineering of the IMP hub gene in A. gossypii
To analyze the effect of the ADE12 gene-deletion on 
riboflavin production in A. gossypii a gene knockout 
strain was constructed using a loxP-KanMX-loxP selec-
tion marker flanked by ADE12-flanking recombinogenic 
sequences, as described above (see “Methods” section). 
As expected, the ade12∆ strain was viable but showed 































































Fig. 4 Overexpression of the RIB genes in a single strain of A. gossypii. a Pipeline of the construction of the A329 strain and b quatification of ribofla‑
vin production in the A. gossypii strains. The data are the means of three independent experiments performed in duplicate
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revealed that the ade12∆ strain was able to produce 
up to 246  mg/L of riboflavin, which represents a 2.5-
fold increase in riboflavin production compared to the 
wild-type strain. In this sense, our results confirm the 
idea of GTP availability as a limiting step for riboflavin 
overproduction.
Although the deletion of ADE12 triggers the produc-
tion of riboflavin, the presence of auxotrophic muta-
tions in the strains is highly undesirable for large-scale 
industrial fermentations. Therefore, we decided to 
analyze the effect of ADE12 gene underexpression on 
riboflavin production. As shown above, the RIB7 gene 
has very low levels of mRNA in the WT strain. Indeed, 
a qRT-PCR analysis revealed that the transcription 
rate of RIB7 was approximately 62-fold lower than 
that of the ADE12 gene. Accordingly, the promoter 
sequence of the RIB7 gene (PRIB7) was used for ADE12 
gene underexpression. Thus, the ADE12 native pro-
moter was replaced by PRIB7 using a loxP-KanMX-loxP 
selection marker, which was subsequently eliminated 
as described above (Fig.  5a). The promoter replace-
ment was confirmed both by DNA sequencing of the 
genomic amplicon (data not shown) and by qRT-PCR 
analysis. As expected, the mRNA levels of ADE12 were 
extremely reduced in the PRIB7-ADE12 strain (approxi-
mately 70-fold lower than those in the wild-type strain). 
However, this transcription level was sufficient to sus-
tain the growth of the mutant in MA2 media without 
adenine supplementation. Moreover, the underexpres-
sion of ADE12 did not significantly affect biomass for-
mation and riboflavin production was similar to that of 
the ade12∆ strain (Fig. 5b).
Engineering the metabolism of purines and overexpression 
of the RIB genes trigger riboflavin overproduction
As shown above, the supply of guanine precursors and 
the transcription of the RIB genes largely determine the 
riboflavin yield in A. gossypii. Accordingly, in order to 
analyze the a riboflavin overproducer strain, we decided 
to combine both the overexpression of the RIB genes and 
the underexpression of the ADE12 gene.
The quintuple RIB-engineered strain A329, which over-
expresses the RIB1, RIB2, RIB3, RIB5 and RIB7 genes, 
was transformed with either the ade12∆ deletion cas-
sette or the PRIB7 cassette to replace the ADE12 native 
promoter. The genomic integrations of each module were 
confirmed both by analytical PCR and qRT-PCR to test 
ADE12 mRNA (data not shown). Other parameters, such 
as the growth rate, biomass production and sporulation 
ability, were analyzed but no significant differences were 
found between these new strains and the wild-type strain 
(data not shown). Finally, a marked increase in ribofla-
vin production was found when these two approaches 
were conjugated in a single strain (Fig.  6). A total yield 
of 523 mg/L of riboflavin was obtained when the overex-
pression of RIB genes and the underexpression of ADE12 
were combined. This riboflavin level in our mutant strain 
represents an increase of 5.4-fold with respect to produc-
tion by the wild-type strain (Fig. 6).
Discussion
Riboflavin production by microbial fermentation is a 
paradigm of a biotechnological process that has replaced 
chemical synthesis in the industry. Although different 




















pADE12 ADE12 CDS tADE12




Fig. 5 Underexpression of the ADE12 gene in A. gossypii. a Diagram of the promoter replacement of the ADE12 gene and b biomass and ribo‑
flavin production analyses after the underexpression of the ADE12 gene in A. gossypii. The data are the means of three independent experiments 
performed in duplicate
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riboflavin, A. gossypii has proved to be one of the most 
effective producers for industry [2, 16]. Accordingly, 
the metabolic engineering of A. gossypii for riboflavin 
overproduction represents an important challenge for 
research in biotechnology.
The transcription of the RIB genes in A. gossypii has 
been analyzed during both the trophic and production 
phases. We found that the RIB4 gene was highly tran-
scribed, mainly during the production (stationary) phase, 
which might indicate the presence of an inducible pro-
moter within the RIB4 sequence. In fact, according to 
previously published transcriptomic data, RIB4 is the 
28th most abundant RNA during the stationary phase in 
A. gossypii [17]. Therefore, the RIB4 promoter could be 
an interesting genetic tool for the overexpression of tar-
get proteins during the stationary phase in A. gossypii. 
In contrast to RIB4, the RIB2 and RIB7 genes were very 
poorly transcribed during A. gossypii growth and pro-
duction phases. Indeed, the substitution of the ADE12 
native promoter by the RIB7 promoter was sufficient to 
minimize the activity of ADE12 and the metabolic flux 
towards AMP synthesis. This represents proof of concept 
for the use of the RIB7 promoter for gene underexpres-
sion in A. gossypii. This strategy may be very useful as a 
new molecular tool both to prevent undesired auxotro-
phies in industrial strains and also to study the effect of 
the downregulation of essential genes.
We found that overexpression of RIB1 and RIB3 (either 
single or combined overexpression) triggered a high 
increase in riboflavin yield, which indicates that the first 
steps of each branch of the riboflavin biosynthetic path-
way (governed by the RIB1 and RIB3 genes) are important 
control points for riboflavin production. Nevertheless, 
the quintuple overexpressing strain rendered the highest 
level of riboflavin production, affording 326.6 mg/L. All 
together, these results suggest that all the RIB genes are 
coordinately expressed so that the control of riboflavin 
production in A. gossypii is more or less evenly distrib-
uted over all the genes and enzymes of the RIB pathway 
and lacks strong controlling individual steps.
It has been previously shown that increasing the pool 
of metabolic precursors from the purine pathway also 
induces a significant overproduction of riboflavin in A. 
gossypii [7–9, 18]. In this regard, an in silico analysis of 
the biosynthesis of riboflavin using the genome-scale 
metabolic model iRL766 [4] predicted an increase in 
riboflavin production by reducing the competing branch 
leading to AMP synthesis. Accordingly, the deletion or 
underexpression of ADE12 caused an enhancement of 
riboflavin accumulation, thus supporting the idea that 
the availability of the immediate precursor of riboflavin 
biosynthesis is another metabolic restriction for ribofla-
vin overproduction.
The overexpression of the RIB genes ensures that the 
cell is devoid of bottlenecks in the riboflavin biosynthetic 
pathway. This provides a cell model system to identify 
new mutations or target genes improving riboflavin pro-
duction that otherwise would be masked by a limiting 
riboflavin biosynthetic pathway. The overexpression of 
the riboflavin pathway is also a strategy of great value for 
further improvement of current industrial strains because 
it is highly unlikely that those strains may have accumu-
lated all the necessary mutations required for overexpres-
sion of all six RIB genes. In this regard, we found that 
the underexpression of the ADE12 gene has an additive 
effect over the overexpression of five RIB genes, provid-
ing the highest yield of riboflavin production obtained by 
metabolic engineering in A. gossypii so far. According to 
our results, metabolic engineering of the IMP hub and 


























Fig. 6 Riboflavin overproduction in the engineered A. gossypii. a quatification of riboflavin production in A. gossypii strains. The data are the means 
of three independent experiments performed in duplicate. b solid MA2 plates of the strains A330, A324 and wild‑type of A. gossypii. The strain A330 
that was modified both for the underexpression of the ADE12 gene and for the overexpression of five RIB genes afforded the highest riboflavin yield 
(in yellow)
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circumvent two important restraints limiting production 
of riboflavin in A. gossypii. We believe that iterative meta-
bolic engineering in combination with fluxomics could 
help drive forward both our understanding of ribofla-
vin metabolism in A. gossypii and the generation of new 
strains with a higher riboflavin production capacity.
Conclusions
We used metabolic engineering to combine the overex-
pression of all the RIB genes with the enhancement of the 
GMP purine branch to generate a strain (A330) that pro-
duces 5.4-fold more riboflavin than the wild-type strain 
(523  mg/L). We foresee that this strategy will provide a 
scalable and controllable way to increase the industrial 
production of this economically important vitamin.
Methods
Ashbya gossypii strains, media, and growth conditions. 
The A. gossypii ATCC 10895 strain was used and con-
sidered a wild-type strain. Other A. gossypii strains used 
in the study are listed in the Additional file 4: Table S2. 
A. gossypii was cultured at 28  °C using either MA2 rich 
medium or synthetic minimal medium lacking adenine 
(SC-ade) [9]. A. gossypii transformation, its sporula-
tion conditions and spores isolation were as previously 
described [9, 19].
Quantitative Real-Time PCR. Quantitative real-time 
PCR (qRT-PCR) was performed with a LightCycler 480 
real-time PCR instrument (Roche), using SYBR green 
I master mix (Roche) and following the manufactur-
er’s instructions. Total RNA samples were obtained as 
described previously [7] and cDNA samples were pre-
pared using the Transcriptor First Strand cDNA Syn-
thesis Kit (Roche). Primer sequences are indicated in 
the Additional file  4: Table  S2. All real-time PCR reac-
tions were performed in duplicate and in at least two 
independent experiments. Quantitative analyses were 
carried out using the LightCycler 480 software. Quanti-
tative values were obtained as the threshold PCR cycle 
number (Ct) when the increase in the fluorescent signal 
of the PCR product showed exponential amplification. 
The target gene mRNA level was normalized to that of 
AgACT1 in the same sample. The relative transcription 
level of the target gene was calculated using the 2−∆∆Ct 
method [20].
Gene overexpression and gene deletion. For gene 
overexpressionAgGPD, the promoter sequence of the 
AgGPD gene was integrated upstream of the ATG ini-
tiator codon of each gene. An overexpression cassette 
comprising the AgGPD promoter (P) and the loxP-
KanMX-loxP selectable marker, conferring resistance 
to geneticin (G418), was PCR-amplified using specific 
primers for each gene (Additional file  4: Table  S2). 
The overexpression modules were used to transform 
spores of A. gossypii and positive clones were selected 
in G418-containing medium. Homokaryon clones 
were obtained by sporulation of the primary transfor-
mants. The correct genomic integration of each over-
expression cassette was confirmed by analytical PCR 
followed by DNA sequencing. Gene overexpression 
was checked by qRT-PCR analysis. For the deletion 
of AgADE12, a gene replacement cassette was con-
structed for the ADE12 gene by PCR amplification of 
the loxP-KanMX-loxP marker (see primer sequences 
in the Additional file  4: Table  S2). The replacement 
cassette was used to transform spores of A. gossypii. 
Primary transformants were selected in G418-con-
taining medium and homokaryon clones were iso-
lated by sporulation of the primary transformants. The 
homologous integration of the replacement cassette 
was confirmed by analytical PCR followed by DNA 
sequencing.
Determination of riboflavin production. Riboflavin 
was measured using a spectrophotometric method. 
Briefly, a volume of 1 mL of the culture was harvested 
and mixed with 1 mL of 0.1 N HCl. The suspension was 
heated at 100 °C for 30 min. Then, samples were cooled 
down and mycelia were broken using glass beads. The 
liquid phase containing both extracellular and intracel-
lular riboflavin was recovered and used for riboflavin 
determination. A calibration curve was performed using 
pure riboflavin (Sigma-Aldrich), which was processed in 
an identical way to the samples. Riboflavin concentra-
tion was determined by reading the absorbance of each 
sample at 450 nm. Measurements were performed using 
a Varioskan microtiter plate reader (Thermo Scientific).
In silico flux balance analysis. Flux balance analysis cal-
culations were performed using MATLAB (Mathworks, 
Natick, MA) and the Raven toolbox [21]. The iRL766 
genomic scale model for A. gossypii was used [4]. To cal-
culate the maximum theoretical yields, riboflavin pro-
duction reaction ‘RFLAVxtO’ was set as the objective 
function and the system of linear equations was solved. 
Biomass and glucose uptake were constrained to 0.09 h−1 
and 1  mmol/gh, respectively, while NH3, sulfate, phos-
phate and adenine remained opened. The flux through 
ADE12 was fixed to 0.0117 mmol/gh (the maximum the-
oretical rate) and reduced manually to simulate a reduc-
tion in its metabolic flux. The model simulates adenine 
utilization from the salvage purine pathway, which allows 
normal growth even when the de novo pathway for ade-
nine biosynthesis is limited. The on line tool Biomet tool-
box 2.0 (http://biomet-toolbox.org/) was used to check 
the flux balance analysis.
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